Pediatr. Res. 2020 Feb 01
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).
McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Initial trials of lung-targeted budesonide (0.25?mg/kg) in surfactant to prevent bronchopulmonary dysplasia (BPD) in premature infants have shown bene ...
Read More
Source: PubMed
J. Pediatr. 2020 Jan 28
High dose steroids for prevention of bronchopulmonary dysplasia-Recommended?
Anne RP, Oleti TP
Read More
Source: PubMed
J. Vasc. Surg. 2020 Jan 28
Incidence, predictors, and outcomes of spinal cord ischemia in elective complex endovascular aortic repair: An analysis of health insurance claims.
Heidemann F, Kölbel T, Kuchenbecker J, Kreutzburg T, Debus ES, Larena-Avellaneda A, Dankhoff M, Behrendt CA
This study aimed to determine predictors and outcomes associated with spinal cord ischemia (SCI) after elective fenestrated or branched endovascular a ...
Read More
Source: PubMed
Trials
Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X, Xia Y, Zhou O, Song Y, Zhang X, Tian D, Li Q, Shu C, Liu E, Yuan X, He L, Liu C, Li J, Liang X, Yang K, Fu Z, Zou L, Bao L, Dai J
Bronchopulmonary dysplasia (BPD) is a complex lung pathological lesion secondary to multiple factors and one of the most common chronic lung diseases. ...
Read More
Source: PubMed
J. Hazard. Mater.
Sex difference in bronchopulmonary dysplasia of offspring in response to maternal PM2.5 exposure.
Yue H, Ji X, Ku T, Li G, Sang N
The adverse effects of fine particulate matters (PM2.5) on respiratory diseases start in utero. In order to investigate whether maternal PM2.5 exposur ...
Read More
Source: PubMed
